Radek Spisek is the founder of Sotio. Sotio has raised $316M in total funding. Backed by PPF Group. Based in Prague, Czech Republic.
Radek Spisek, Ph.D. is the CEO of Sotio, a Czech Republic-based immuno-oncology company specializing in cancer drugs. The company secured a significant 280 million euro ($316 million) funding round in December 2021 to advance its clinical pipeline, including its lead asset SOT101, an IL-15 superagonist, and its next-gen CAR-T program BOXR1030.
Full founder directory · Investor directory · Company funding database · Fundraising library